These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30894487)

  • 1. Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis.
    Baragaña B; Forte B; Choi R; Nakazawa Hewitt S; Bueren-Calabuig JA; Pisco JP; Peet C; Dranow DM; Robinson DA; Jansen C; Norcross NR; Vinayak S; Anderson M; Brooks CF; Cooper CA; Damerow S; Delves M; Dowers K; Duffy J; Edwards TE; Hallyburton I; Horst BG; Hulverson MA; Ferguson L; Jiménez-Díaz MB; Jumani RS; Lorimer DD; Love MS; Maher S; Matthews H; McNamara CW; Miller P; O'Neill S; Ojo KK; Osuna-Cabello M; Pinto E; Post J; Riley J; Rottmann M; Sanz LM; Scullion P; Sharma A; Shepherd SM; Shishikura Y; Simeons FRC; Stebbins EE; Stojanovski L; Straschil U; Tamaki FK; Tamjar J; Torrie LS; Vantaux A; Witkowski B; Wittlin S; Yogavel M; Zuccotto F; Angulo-Barturen I; Sinden R; Baum J; Gamo FJ; Mäser P; Kyle DE; Winzeler EA; Myler PJ; Wyatt PG; Floyd D; Matthews D; Sharma A; Striepen B; Huston CD; Gray DW; Fairlamb AH; Pisliakov AV; Walpole C; Read KD; Van Voorhis WC; Gilbert IH
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7015-7020. PubMed ID: 30894487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side chain rotameric changes and backbone dynamics enable specific cladosporin binding in Plasmodium falciparum lysyl-tRNA synthetase.
    Chhibber-Goel J; Sharma A
    Proteins; 2019 Sep; 87(9):730-737. PubMed ID: 31017332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural analyses of the malaria parasite aminoacyl-tRNA synthetases provide new avenues for antimalarial drug discovery.
    Chhibber-Goel J; Yogavel M; Sharma A
    Protein Sci; 2021 Sep; 30(9):1793-1803. PubMed ID: 34184352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin.
    Hoepfner D; McNamara CW; Lim CS; Studer C; Riedl R; Aust T; McCormack SL; Plouffe DM; Meister S; Schuierer S; Plikat U; Hartmann N; Staedtler F; Cotesta S; Schmitt EK; Petersen F; Supek F; Glynne RJ; Tallarico JA; Porter JA; Fishman MC; Bodenreider C; Diagana TT; Movva NR; Winzeler EA
    Cell Host Microbe; 2012 Jun; 11(6):654-63. PubMed ID: 22704625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Synthesis of Metabolically Stable tRNA Synthetase Inhibitors Derived from Cladosporin.
    Rusch M; Thevenon A; Hoepfner D; Aust T; Studer C; Patoor M; Rollin P; Livendahl M; Ranieri B; Schmitt E; Spanka C; Gademann K; Bouchez LC
    Chembiochem; 2019 Mar; 20(5):644-649. PubMed ID: 30462880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cladosporin, A Highly Potent Antimalaria Drug?
    Hou A; Li B; Deng Z; Xu M; Dickschat JS
    Chembiochem; 2023 Jun; 24(12):e202300154. PubMed ID: 37158666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action studies confirm on-target engagement of lysyl-tRNA synthetase inhibitor and lead to new selection marker for
    Hanna JC; Corpas-Lopez V; Seizova S; Colon BL; Bacchetti R; Hall GMJ; Sands EM; Robinson L; Baragaña B; Wyllie S; Pawlowic MC
    Front Cell Infect Microbiol; 2023; 13():1236814. PubMed ID: 37600947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Plasmodium falciparum Lysyl-tRNA Synthetase via a Piperidine-Ring Scaffold Inspired Cladosporin Analogues.
    Babbar P; Sato M; Manickam Y; Mishra S; Harlos K; Gupta S; Parvez S; Kikuchi H; Sharma A
    Chembiochem; 2021 Jul; 22(14):2468-2477. PubMed ID: 33969584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of malaria parasite lysyl-tRNA synthetase inhibition by cladosporin.
    Khan S; Sharma A; Belrhali H; Yogavel M; Sharma A
    J Struct Funct Genomics; 2014 Jun; 15(2):63-71. PubMed ID: 24935905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
    Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
    J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis.
    Jain V; Yogavel M; Kikuchi H; Oshima Y; Hariguchi N; Matsumoto M; Goel P; Touquet B; Jumani RS; Tacchini-Cottier F; Harlos K; Huston CD; Hakimi MA; Sharma A
    Structure; 2017 Oct; 25(10):1495-1505.e6. PubMed ID: 28867614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum Apicomplexan-Specific Glucosamine-6-Phosphate
    Chi J; Cova M; de Las Rivas M; Medina A; Borges RJ; Leivar P; Planas A; Usón I; Hurtado-Guerrero R; Izquierdo L
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cladosporin Derivatives Obtained by Biotransformation Provide Guidance for the Focused Derivatization of this Antimalarial Lead Compound.
    Fredenhagen A; Schroer K; Schröder H; Hoepfner D; Ligibel M; Porchet Zemp L; Radoch C; Freund E; Meishammer A
    Chembiochem; 2019 Mar; 20(5):650-654. PubMed ID: 30347507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.
    Herman JD; Pepper LR; Cortese JF; Estiu G; Galinsky K; Zuzarte-Luis V; Derbyshire ER; Ribacke U; Lukens AK; Santos SA; Patel V; Clish CB; Sullivan WJ; Zhou H; Bopp SE; Schimmel P; Lindquist S; Clardy J; Mota MM; Keller TL; Whitman M; Wiest O; Wirth DF; Mazitschek R
    Sci Transl Med; 2015 May; 7(288):288ra77. PubMed ID: 25995223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-guided conversion from an anaplastic lymphoma kinase inhibitor into Plasmodium lysyl-tRNA synthetase selective inhibitors.
    Zhou J; Xia M; Huang Z; Qiao H; Yang G; Qian Y; Li P; Zhang Z; Gao X; Jiang L; Wang J; Li W; Fang P
    Commun Biol; 2024 Jun; 7(1):742. PubMed ID: 38890421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.
    Ndao M; Nath-Chowdhury M; Sajid M; Marcus V; Mashiyama ST; Sakanari J; Chow E; Mackey Z; Land KM; Jacobson MP; Kalyanaraman C; McKerrow JH; Arrowood MJ; Caffrey CR
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6063-73. PubMed ID: 24060869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The growing pipeline of natural aminoacyl-tRNA synthetase inhibitors for malaria treatment.
    Saint-Léger A; Sinadinos C; Ribas de Pouplana L
    Bioengineered; 2016 Apr; 7(2):60-4. PubMed ID: 26963157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.
    Jumani RS; Bessoff K; Love MS; Miller P; Stebbins EE; Teixeira JE; Campbell MA; Meyers MJ; Zambriski JA; Nunez V; Woods AK; McNamara CW; Huston CD
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomic Resolution Analyses of Isocoumarin Derivatives for Inhibition of Lysyl-tRNA Synthetase.
    Zhou J; Zheng L; Hei Z; Li W; Wang J; Yu B; Fang P
    ACS Chem Biol; 2020 Apr; 15(4):1016-1025. PubMed ID: 32195573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein Translation Enzyme lysyl-tRNA Synthetase Presents a New Target for Drug Development against Causative Agents of Loiasis and Schistosomiasis.
    Sharma A; Sharma M; Yogavel M; Sharma A
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005084. PubMed ID: 27806050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.